Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Delmosart
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Delmosart 36mg modified-release tablets
0404000M0BJACAN
|
Delmosart | Methylphenidate hydrochloride | Central Nervous System | 2,103 |
|
Delmosart 54mg modified-release tablets
0404000M0BJADAR
|
Delmosart | Methylphenidate hydrochloride | Central Nervous System | 2,093 |
|
Delmosart 27mg modified-release tablets
0404000M0BJABAT
|
Delmosart | Methylphenidate hydrochloride | Central Nervous System | 1,639 |
|
Delmosart 18mg modified-release tablets
0404000M0BJAAAM
|
Delmosart | Methylphenidate hydrochloride | Central Nervous System | 1,201 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.